CPC A61K 31/58 (2013.01) [A61K 31/7068 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07J 43/003 (2013.01)] | 14 Claims |
1. A pharmaceutical composition for treating pancreatic cancer, comprising:
a compound that is at least one selected from the group consisting of
and a pharmaceutically acceptable salt thereof.
|